StockGlow

BioPorto A/S (BIOPOR.CO)

Develops blood and urine tests that detect kidney injury in critically ill patients early.

1.21+0.00%Healthcare
Compare BIOPOR.CO with
StockGlow Score
82
Bullish
BearishBullish
1 year ago-6.6%

The outlook

BioPorto trades at 1.205, positioned midway through its 52-week range and above both its 50- and 200-day moving averages. Analyst coverage shows an average price target roughly 45% above the current level. The overall sentiment leans bullish based on available market data.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range56% of the way from its 52-week low to high
Price targetAvg target +45% vs current price
Market cap
$596.6M
52-wk high
1.49
52-wk low
0.84
50-day avg
1.17
200-day avg
1.07
Trailing P/E
—

Similar stocks

AMBU-B.COAmbu A/S$72.25-0.48%BAVA.COBavarian Nordic A/S$179.00+0.34%CBRAIN.COcBrain A/S$51.40+1.18%CHEMM.COChemoMetec A/S$414.80+0.39%EXPRS2.STExpreS2ion Biotech Holding AB (publ)$1.39-1.07%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy